“…In studies of predominately symptomatic women in the United States, Canada, Australia, Malaysia, Egypt, and India, the BVBlue test's sensitivity (range, 88%-100%) and specificity (range, 85%-99%) were high compared with BV by Nugent score. [11][12][13][14][15] However, the test performed poorly in one study in the United States including asymptomatic and symptomatic women, in symptomatic women in sub-Saharan Africa (Uganda, Zimbabwe, South Africa), and in Indian women with vaginal pH >4.5; sensitivity ranged from 38% to 61%. [16][17][18] Compared with the study of symptomatic women in Uganda, Zimbabwe, and South Africa reporting an overall sensitivity of 52%, 17 the BVBlue test performed better in this study of Kenyan women (overall sensitivity, 82%; self-reported abnormal vaginal discharge sensitivity, 74%).…”